Search Results for: log in

Women’s Health Week: Common diseases and screening tests

woman at doctor with test results

National Women’s Health Week is an annual initiative driven by the U.S. Department of Health and Human Services that aims to raise awareness and encourage women to make their health a priority. While finding the time and resources to properly manage one’s health may feel overwhelming, there are many actionable ways women can take to […]

Sexually Transmitted Infections (STI): Awareness & Prevention

Happy multicultural couples. Resources for STI Awareness Month.

No matter age or background, there are about 20 million new sexually transmitted infection cases every year in the US, according to ASHA. Anyone that is sexually active can become infected with a sexually transmitted infection or STI, according to the CDC. However, there are some groups that are more affected: adolescents, young adults, pregnant […]

Go Blue for Colorectal Cancer Awareness Month 

Person wearing a white shirt holding a blue ribbon

Colorectal cancer is the third most common cancer diagnosed in both men and women each year in the United States, excluding skin cancer. About 1 in 25 people in the U.S. will develop colorectal cancer during their lifetime, according to the American Cancer Society; however, with regular screening, it can be detected early.1 What is […]

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

Quote: We’re proud to be offering our patients more clarity and information that can empower them to better manage and understand their health

CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]

A Renewed Purpose: Science, Service and Innovation

You might have noticed an update in our name from BioReference Laboratories, Inc. to BioReference Health, LLC. While it may be a small shift in what we call ourselves, our new identity represents a significant difference in how we deliver our solutions and services. For more than four decades, BioReference has built a legacy based […]

Aspira Women’s Health, BioReference to distribute blood tests to detect the risk of ovarian malignancy

LabPulse.com Aspira Women’s Health on Wednesday announced a collaboration for ovarian cancer testing with Opko Health’s BioReference Laboratories. The firms will co-market and distribute Aspira’s Ova1Plus, which combines its U.S. Food and Drug Administration-cleared blood tests, Ova1 and Overa, to detect the risk of ovarian malignancy in women with adnexal masses prior to surgery. Under the […]

Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference

Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]

Women’s Health Highlight | SMA Awareness Month

Spinal muscular atrophy (SMA) affects 1 per 8,000 to 10,000 people around the world, according to the National Library of Medicine.1 For SMA Awareness Month, we’re bringing attention to this genetic disorder by highlighting information about how the disease is inherited and the options for SMA testing during pregnancy or preconception. What Is SMA? Spinal […]

Heading Back to College? Study-Up on STI Prevention & Testing

If you’re packing up to head back to campus or are sending off a scholar – the start of a new semester is the perfect time to encourage sexual health education. Staying informed about the heightened risk for sexually transmitted infections that college students may face is an important factor in supporting sexual and overall […]

OPKO Health Announces Leadership Changes for BioReference Laboratories

OPKO Press Release MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his role as Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President and a Director of OPKO. He will remain as […]